MoneyWorks4Me

Gufic Biosciences informs about transcript of earnings call

23 Nov 2023 Evaluate

In continuation to communication dated November 17, 2023 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Gufic Biosciences has informed that written transcript of the said call held on November 17, 2023 at 4:30 pm, has been uploaded on the Company’s website (link attached).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..